| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/12/2001 | CN2464337Y Medicinal plaster for promoting menstrual flow and blood circulation |
| 12/12/2001 | CN1326478A Membrane or matrix for controlling drug permeation |
| 12/12/2001 | CN1326471A Polymer combining with phosphoric acid and preparation containing the same |
| 12/12/2001 | CN1326455A Improved chemical process and pharmaceutical formulation |
| 12/12/2001 | CN1326364A Antiviral formulations comprising propylene glycol and isopropyl alkanoic acid ester |
| 12/12/2001 | CN1326363A Suppositories |
| 12/12/2001 | CN1326350A Fluticasone lotion having improved vasoconstrictor activity |
| 12/12/2001 | CN1326341A Dry powder for inhalation |
| 12/12/2001 | CN1326340A Pharmaceutical composition for treatment of acute disorders |
| 12/12/2001 | CN1326339A Controlled release bead, method of producing the same and multiple unit formulation comprising it |
| 12/12/2001 | CN1326338A Process for preparing oral calcium compositions |
| 12/12/2001 | CN1326337A Drug delivery device, especially for delivery of progestins and estrogens |
| 12/12/2001 | CN1326335A Process for the manufacture of liquid filled capsules |
| 12/12/2001 | CN1326318A Antiparasitic formulations |
| 12/12/2001 | CN1325728A Superfine cordyceps powder and its prepairng process |
| 12/12/2001 | CN1325719A Antalgesic liquid for cervical dilatation |
| 12/12/2001 | CN1325718A Freeze dried compound queen bee powder |
| 12/12/2001 | CN1325711A Antihypertensive lozenge for regenerating Qi and blood and its preparing process |
| 12/12/2001 | CN1325693A Process for preparing ginseng extract powder |
| 12/12/2001 | CN1325688A Process for preparing high-activity soft capsules of forest frog's oviduct fat |
| 12/12/2001 | CN1325683A Process for preparing Tebitan medicine pills |
| 12/12/2001 | CN1075959C Radioactive particulate material, preparation and use thereof |
| 12/12/2001 | CN1075948C External-used medicine for treating protrusion of intervertebral disc |
| 12/12/2001 | CN1075946C Process for preparing synergetic antimalarial-compound naphthoquine phosphate |
| 12/12/2001 | CN1075945C High-polymer encapsulated insulin microsome and its preparation method and use |
| 12/11/2001 | US6330471 Iontophoresis electrode device |
| 12/11/2001 | US6329414 Synthetic or naturally occurring phytonutrient of canthanaxin, limonene and/or vitamin a; cytoprotective selected from d- or l-histidine, racemic, non-racemic mixture, nutriceutically inert carrier, such as microcrystalline cellulose |
| 12/11/2001 | US6329413 Stable oil-in-water emulsion; anionic or nonionic hydrophilic, water soluble emulsifier; galactoarabinan, polygalactose, or polyarabinose; skin protectant |
| 12/11/2001 | US6329410 Water-base liquid preparation |
| 12/11/2001 | US6329404 Pharmaceutical composition |
| 12/11/2001 | US6329341 Method of treating septic shock |
| 12/11/2001 | US6328997 Magnesium bicarbonate |
| 12/11/2001 | US6328996 Polypeptide capable of contacted state and relaxed state |
| 12/11/2001 | US6328995 Stable vitamin and/or carotenoid products in powder form and process for their production |
| 12/11/2001 | US6328994 Orally disintegrable tablets |
| 12/11/2001 | US6328993 Oral administration form for an acid liable active proton pump inhibitor |
| 12/11/2001 | US6328992 Cannabinoid patch and method for cannabis transdermal delivery |
| 12/11/2001 | US6328991 Composition and method for prevention of sexually transmitted diseases, including aids |
| 12/11/2001 | US6328988 Hyperbranched polymeric micelles for encapsulation and delivery of hydrophobic molecules |
| 12/11/2001 | US6328984 Selective antibacterial composition |
| 12/11/2001 | US6328983 Cosmetics, skin treatments |
| 12/11/2001 | US6328982 Cool feeling composition |
| 12/11/2001 | US6328980 Emulsion composition comprising a fluorohydrocarbon compound and a method for preparing |
| 12/11/2001 | US6328979 Sustained release medicinal compositions |
| 12/11/2001 | US6328972 Compositions and methods for inducing cytotoxic T lymphocyte responses by immunization with protein antigens |
| 12/11/2001 | US6328967 Delivery system to modulate immune response |
| 12/11/2001 | US6328950 Pigment-containing foamable gel and device producing a foam from said gel |
| 12/11/2001 | US6328728 Drug delivery from electrotransport device, dissolving or suspension intensifiers, agar beads, buffers |
| 12/11/2001 | US6328708 Device for controlled anaesthesia, analgesia and /or sedation |
| 12/11/2001 | CA2218643C Oral pharmaceutical composition of piperidinoalkanol compounds in solution form |
| 12/11/2001 | CA2141788C Controlled release pharmaceutical formulations of 3'-azido-3'-deoxythymidine and methods of use |
| 12/11/2001 | CA2063883C Long-acting biodegradable microparticles and a process for their preparation |
| 12/08/2001 | CA2347316A1 Growth promoting pharmaceutical implant |
| 12/06/2001 | WO2001092580A2 Lyophilizable and enhanced compacted nucleic acids |
| 12/06/2001 | WO2001092401A2 Highly flexible starch-based films |
| 12/06/2001 | WO2001092400A2 Highly flexible starch-based films |
| 12/06/2001 | WO2001092334A1 Glucose dependent release of insulin from glucose sensing insulin derivatives |
| 12/06/2001 | WO2001092268A1 Process for drying amoxicillin |
| 12/06/2001 | WO2001092157A1 Micronised barium sulphate |
| 12/06/2001 | WO2001091902A2 Methods and devices for sealing microchip reservoir devices |
| 12/06/2001 | WO2001091892A1 Method for producing emulsified composition |
| 12/06/2001 | WO2001091814A2 Polyubiquitin based hydrogel and uses thereof |
| 12/06/2001 | WO2001091803A2 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 12/06/2001 | WO2001091784A1 Means for maintenance and/or correction of glucose concentration in blood |
| 12/06/2001 | WO2001091783A2 Methods and compositions for producing a neurosalutary effect in a subject |
| 12/06/2001 | WO2001091782A1 Pralmorelin-containing nasal drop preparations |
| 12/06/2001 | WO2001091761A1 Matrices for oral preparations |
| 12/06/2001 | WO2001091757A1 Percutaneous absorption type steroid preparation for external use |
| 12/06/2001 | WO2001091751A1 New pharmaceutical composition and the process for its preparation |
| 12/06/2001 | WO2001091750A1 Use of a celecoxib composition for fast pain relief |
| 12/06/2001 | WO2001091743A1 Patch containing 4-biphenylacetic acid |
| 12/06/2001 | WO2001091742A1 Pharmaceutical composition containing at least a polymer associated or conjugated with at least a phenylalkylcarboxylic acid salt, conjugate polymers and uses thereof |
| 12/06/2001 | WO2001091732A2 Medicament for combating respiratory depression |
| 12/06/2001 | WO2001091731A1 Pharmaceutical compositions of 2'-deoxy-2'-(fluoromethylene)cytidine |
| 12/06/2001 | WO2001091730A1 Mineral supplement |
| 12/06/2001 | WO2001091729A1 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 12/06/2001 | WO2001091728A2 Nanoemulsion formulations |
| 12/06/2001 | WO2001091727A2 Self-emulsifying active substance formulation and use of this formulation |
| 12/06/2001 | WO2001091726A1 Acne-treating composition |
| 12/06/2001 | WO2001091725A2 Biologically useful polyphosphates |
| 12/06/2001 | WO2001091724A2 Transdermal delivery of lasofoxifene |
| 12/06/2001 | WO2001091723A2 Fluorinated copolymer surfactants and use thereof in aerosol compositions |
| 12/06/2001 | WO2001091722A2 Water-thin emulsions with low emulsifier levels |
| 12/06/2001 | WO2001091721A2 Modified starch as a replacement for gelatin in soft gel films and capsules |
| 12/06/2001 | WO2001091720A2 Preparation of injectable suspensions having improved injectability |
| 12/06/2001 | WO2001091719A1 Nasal ointment based on white petroleum jelly |
| 12/06/2001 | WO2001091718A2 Occlusive transdermal therapeutic system wit a non-occlusive backing layer |
| 12/06/2001 | WO2001091717A1 Oral delivery form comprising glipizide |
| 12/06/2001 | WO2001091716A1 Peroral therapeutic system comprising glipizide |
| 12/06/2001 | WO2001091703A2 Low emulsifier multiple emulsions |
| 12/06/2001 | WO2001091696A2 Use of biguanide derivatives for making a medicine having a wound healing effect |
| 12/06/2001 | WO2001091682A1 Composition and applicator for topical substance delivery |
| 12/06/2001 | WO2001091588A1 Primary composition containing a lipophilic bioactive compound |
| 12/06/2001 | WO2001091576A1 Granular vitamin composition |
| 12/06/2001 | WO2001091553A1 Composite wafer for controlled drug delivery |
| 12/06/2001 | WO2001064329A8 Microcapsule, in particular, for immobilizing organic or inorganic solids, liquids and/or gases |
| 12/06/2001 | WO2001062760A3 A NOVEL CRYSTALLINE FORM OF N-[4-[2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO[2,3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR |
| 12/06/2001 | WO2001062226A3 Homogenous solid matrix containing vegetable proteins |
| 12/06/2001 | WO2001060339A3 Method for the preparation of microspheres which contain colloidal systems |
| 12/06/2001 | WO2001056545A3 Sustained-release microencapsulated delivery system |